Evidence map›Paper›PMID 40873287›Full record

ArticleCurrent Alzheimer research2025

Topological Biomarkers of Alzheimer's Disease from Functional Brain Network Analysis.

Soudeh Behrouzinia, Alireza Khanteymoori

Abstract read
PubMed Publisher
In one paragraph

Article in Current Alzheimer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Soudeh BehrouziniaDepartment of Computer Engineering, Faculty of Engineering, University of Zanjan, Zanjan, Iran.
Alireza KhanteymooriDepartment of Psychology, University of Freiburg, Freiburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAlzheimer's disease is a progressive neurodegenerative condition characterized by the gradual deterioration of cognitive functions. Early identification of functional brain changes is crucial for timely diagnosis and effective intervention. This study employs multiplex network analysis to examine alterations in brain connectivity topology associated with Alzheimer's Disease, to identify early biomarkers and uncover potential therapeutic targets.

methodsThis study presents a secondary cross-sectional analysis based on a publicly available EEG dataset comprising spectral coherence measurements from 25 patients with clinically diagnosed Alzheimer's Disease (AD) and 25 age- and gender-matched Healthy Controls (HC). Functional connectivity matrices were generated across seven distinct frequency bands, with each brain region modeled as a network node and inter-regional coherence values represented as weighted edges. These matrices were then used to construct multiplex brain networks, which were rigorously analyzed using graph-theoretical approaches. The analysis encompassed key metrics, including modularity, centrality measures (Betweenness and MultiRank), motif distribution, and network controllability, to characterize and compare the underlying patterns of functional brain organization in AD and healthy aging.

resultsNetworks associated with AD exhibited significantly reduced modularity, disrupted centrality patterns, and a higher occurrence of 2 and 3-node motifs, indicating local reorganization of connectivity. Additionally, the spatial distribution of driver nodes was markedly altered in AD. Centrality analyses revealed a pronounced shift in network hubs toward the temporal and insular cortices, suggesting compensatory or pathological reallocation of influence. Controllability assessments demonstrated a lower energy requirement for network control in AD, accompanied by increased inter-layer fragmentation, reflecting compromised integrative function across frequency bands. DISCUSSION: The findings revealed specific topological alterations, including reduced modularity, altered centrality, and decreased controllability, all of which are closely linked to AD-related network degeneration. By leveraging multi-frequency EEG data, the multiplex approach shows significant clinical potential for monitoring disease progression and supporting personalized treatments, with the ability to detect subtle connectivity disruptions before cognitive symptoms manifest.

conclusionMultiplex network analysis reveals distinct and robust alterations in the functional brain architecture of individuals with Alzheimer's Disease. These network-level disruptions offer valuable insights into the pathophysiology of AD and highlight potential avenues for early diagnosis and targeted therapeutic strategies aimed at preserving cognitive function.

Indexed as

Alzheimer DiseaseBrainNerve NetAgedAged, 80 and overBiomarkersCross-Sectional StudiesElectroencephalographyFemaleHumansMaleMiddle AgedNeural PathwaysBiomarkersAlzheimer’s diseasebrain networkscomplex networkscontrollabilitymultiplex networksneurodegeneration.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.